title: Treatment of benign prostatic hyperplasia at Mater Hospital, Nairobi.
abstract: OBJECTIVE
  To evaluate the use of medical therapy in the management of patients with mild, moderate and severe symptoms of benign prostatic hyperplasia.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  Private urology clinic in Mater Hospital, Nairobi between 1995 and 2005.
  
  
  METHODS
  Six hundred and eighty patients with benign prostatic hypertrophy aged 50-80 years.
  
  
  RESULTS
  Two hundred and eighty (43.8%) patients benefited from the drug treatment alone and were released from the clinic follow up after five years. Two hundred and seventy (42.2%) cases could not complete the five years follow up on drugs alone due to symptoms recurrence or severity or unavailability of drugs. They were removed from the drugs alone treatment and put on other interventions. Ninety (15.9%) cases were operated on based on their decision and insistence or severity of their symptoms or no drugs response.
  
  
  CONCLUSIONS
  This observational study confirms that medical treatment is beneficial in the management of benign prostatic hyperplasia (BPH) and is cheap and gives better first line option of treatment choice to many patients. It also gives hopes to the surgical risk patients. The quality of life (QOL) of patients and their family disturbance is also improved.
authors.affiliation: Department of Surgery, College of Health Sciences, University of Nairobi, Kenya.
authors.forename: J S
authors.initials: JS
authors.lastname: Oliech
mesh_terms: D000317:Adrenergic alpha-Antagonists; D000368:Aged; D000369:Aged, 80 and over; D006305:Health Status Indicators; D006306:Health Surveys; D006801:Humans; D007630:Kenya; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D018434:Sickness Impact Profile; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000317:Adrenergic alpha-Antagonists